Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes

Cellular and Molecular Life Sciences

Volumn 61, Issue 14, 2004, Pages 1785-1794

  Marty, C ^a   Meylan, C ^a   Schott, H ^b   Ballmer Hofer, K ^a   Schwendener, R A ^a  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antennapedia; Cytotoxic liposome; Heparan sulfate proteoglycan; HIV Tat; Peptide liposome

Indexed keywords

CYTOTOXIC AGENT; DRUG CARRIER; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LIPOSOME; N4 OCTADECYL 1BETA DEXTRO ARABINOFURANOSYLCYTOSINE (5',5') 3' C ETHINYLCYTIDINE; PEPTIDE DERIVATIVE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOMICROSCOPY; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS COUPLING REACTION; CROSS LINKING; CYTOLOGY; CYTOTOXICITY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG POTENCY; FLOW CYTOMETRY; GENE TRANSLOCATION; IC 50; INCUBATION TIME; LAMELLAR BODY; MOUSE; NONHUMAN;

ANIMALIA;

EID: 3843050301     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4166-0     Document Type: Article

References (34)

1. Lindsay M. A. (2002) Peptide-mediated cell delivery: application in protein target validation. Curr. Opin. Pharmacol. 2: 587-594
2. Schwarze S. R., Ho A., Vocero-Akbani A. and Dowdy S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572
3. Derossi D., Joliot A. H., Chassaing G. and Prochiantz A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269: 10444-10450
4. Derossi D., Chassaing G. and Prochiantz A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8: 84-87
5. Lindgren M., Hallbrink M., Prochiantz A. and Langel U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21: 99-103
6. Fischer P. M., Krausz E. and Lane D. P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjug. Chem. 12: 825-841
7. Sapra P. and Allen T. M. (2003) Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42: 439-462
8. Cattaneo-Pangrazzi R. M., Schott H., Wunderli-Allenspach H., Rothen-Rutishauser B., Guenthert M. and Schwendener R. A. (2000) Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-Fd-CydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells. J. Cancer Res. Clin. Oncol. 126: 247-256
9. Mastrobattista E., Koning G. A. and Storm G. (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Adv. Drug Deliv. Rev. 40: 103-127
10. Barratt G. (2003) Colloidal drug carriers: achievements and perspectives. Cell Mol. Life Sci. 60: 21-37
11. Marty C., Odermatt B., Schott H., Neri D., Ballmer-Hofer K., Klemenz R. et al. (2002) Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes. Br. J. Cancer 87: 106-112
12. Belting M. (2003) Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28: 145-151
13. Drin G., Cottin S., Blanc E., Rees A. R. and Temsamani J. (2003) Studies on the internalisation mechanism of cationic cell-penetrating peptides. J. Biol. Chem. 278: 31192-31201
14. Console S., Marty C., Garcia-Echeverria C., Schwendener R. and Ballmer-Hofer K. (2003) Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278: 35109-35114
15. Ou J., Geiger T., Ou Z., Ackerman A. W., Oldham K. T. and Pritchard K. A. (2003) AP-4F, antennapedia peptide linked to an amphipathic alpha helical peptide increases the efficiency of lipofectamine-mediated gene transfection in endothelial cells. Biochem. Biophys. Res. Commun. 305: 605-610
16. Sandgren S., Cheng F. and Belting M. (2002) Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277: 38877-38883
17. Wadia J. S., Stan R. V. and Dowdy S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10: 310-315
18. Koch A. M., Reynolds F., Kircher M. F., Merkle H. P., Weissleder R. and Josephson L. (2003) Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug. Chem. 14: 1115-1121
19. Nori A., Jensen K. D., Tijerina M., Kopeckova P. and Kopecek J. (2003) Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug. Chem. 14: 44-50
20. Torchilin V. P., Rammohan R., Weissig V. and Levchenko T. S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 98: 8786-8791
21. Torchilin V. P., Levchenko T. S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B. and D'Souza G. G. (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA 100: 1972-1977
22. + T cells. J. Immunol. 167: 6462-6470
23. Chikh G., Bally M. and Schutze-Redelmeier M. P. (2001) Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes. J. Immunol. Methods 254: 119-135
24. Cattaneo-Pangrazzi R. M., Schott H. and Schwendener R. A. (2000) The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145. Prostate 45: 8-18
25. Ludewig B., Barchiesi F., Pericin M., Zinkernagel R. M., Hengartner H. and Schwendener R. A. (2000) In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. Vaccine. 19: 23-32
26. Marty C. and Schwendener R. A. (2004) Cytotoxic tumor targeting with scFv antibody modified liposomes. Methods Mol. Biol. in press
27. 4-octadecyl-1-β-D- arabinofuranosylcytosine (NOAC), a new lipophilic derivative of 1-β-D-arabinofuranocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells. Invest New Drugs 19: 203-210
28. Ludwig P. S., Schwendener R. A. and Schott H. (2003) A new laboratory scale synthesis for the anticancer drug 3′-C-ethynylcytidine. Synthesis 16: 2387-2392
29. Vives E., Brodin P. and Lebleu B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272: 16010-16017
30. Drin G., Mazel M., Clair P., Mathieu D., Kaczorek M. and Temsamani J. (2001) Physico-chemical requirements for cellular uptake of pAntp peptide: role of lipid-binding affinity. Eur. J. Biochem. 268: 1304-1314
31. Letoha T., Gaal S., Somlai C., Czajlik A., Perczel A. and Penke B. (2003) Membrane translocation of penetratin and its derivatives in different cell lines. J. Mol. Recognit. 16: 272-279
32. Mislick K. A. and Baldeschwieler J. D. (1996) Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA 93: 12349-12354
33. Gratton J. P., Yu J., Griffith J. W., Babbitt R. W., Scotland R. S., Hickey R. et al. (2003) Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat. Med. 9: 357-363
34. Tyagi M., Rusnati M., Presta M. and Giacca M. (2001) Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276: 3254-3261